CLINICAL_TRIALS
research
· 2026-02-27
Clinical Trial Update: Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr [NA]
Summary
This clinical trial is evaluating PSMA PET-CT imaging for active surveillance in men with prostate cancer to assess its potential utility.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer | NA | Status: RECRUITING